Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ArQule Inc (NASDAQ:ARQL)

1.70
Delayed Data
As of May 27
 +0.05 / +3.03%
Today’s Change
1.37
Today|||52-Week Range
2.65
-21.66%
Year-to-Date
No recent news for ArQule Inc.

Today’s Trading

Previous close1.65
Today’s open1.66
Day’s range1.64 - 1.70
Volume103,576
Average volume (3 months)110,556
Market cap$119.4M
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+40.54%
Earnings growth (this year)-54.55%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)-0.13%
P/E ratioNM
Price/Sales12.13
Price/Book3.62

Competitors

 Today’s
change
Today’s
% change
AFMDAffimed NV-0.03-0.88%
--Sun Biopharma Inc0.000.00%
DPRXDipexium Pharmaceuti...-0.07-0.62%
ORMPOramed Pharmaceutica...-0.07-0.78%
Data as of 4:00pm ET, 05/27/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$11.2M
Annual profit (last year)-$13.8M
Net profit margin-122.56%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Paolo Pucci
President &
Chief Operating Officer
Peter S. Lawrence
Corporate headquarters
Burlington, Massachusetts

Forecasts

Partner Offers

Search for Jobs